Aprotinin use during cardiac surgery: recent alterations and effects on blood product utilization

Journal of Clinical Anesthesia

Volumn 21, Issue 7, 2009, Pages 502-507

  Strouch, Zaneta Y ^a   Drum, Melinda L ^a   Chaney, Mark A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Aprotinin; Cardiac surgery

Indexed keywords

AMINOCAPROIC ACID; APROTININ; FRESH FROZEN PLASMA;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION;

AGED; APROTININ; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DRUG UTILIZATION; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; PLASMA; REOPERATION; RETROSPECTIVE STUDIES;

EID: 71649114873     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2008.12.021     Document Type: Article

References (15)

1. McEvoy M.D., Reeves S.T., Reves J.G., and Spinale F.G. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg 105 (2007) 949-962
2. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
3. Laupacis A., and Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery; meta-analysis using perioperative blood transfusion as the outcome. Anesth Analg 85 (1997) 1258-1267
4. Mangano D.T., Tudor I.C., Dietzel C., and Multicenter Study of Perioperative Ischemia Research Group. Ischemic Research and Education Foundation: the risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
5. Mangano D.T., Miao Y., Vuylsteke A., and Multicenter Study of Perioperative Ischemia Research Group. Ischemia Research and Education Foundation: mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
6. Hill S.E. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 21 (2007) 298-301
7. Augoustides J. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 21 (2007) 302-304
8. Fergusson D.A., Hebert P.C., Mazer C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
9. Koch C.G., Khandwala F., Li L., et al. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 82 (2006) 13-20
10. Brown J.R., Birkmeyer N.J.O., and O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115 (2007) 2801-2813
11. Bridges C.R. Valid comparisons of antifibrinolytic agents used in cardiac surgery. Circulation 115 (2007) 2790-2792
12. Warren O., Mandal K., Hadjianastassiou M.D., et al. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 83 (2007) 707-714
13. Surgenor S.D., DeFoe G.R., Fillinger M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 114 1 Suppl (2006) 143-148
14. Rana R., Fernandez-Perez E.R., Khan S.A., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 46 (2006) 1478-1483
15. Khan H., Belsher J., Yilmaz M., et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131 (2007) 1308-1314